The Journal of Organic Chemistry
Article
the product as white needles (1.06 g; 75%): Rf 0.4 (ethyl acetate/
petroleum ether, 4:1 v/v); mp 59 °C; H NMR (400 MHz, DMSO-
CH2Cl2); 1H NMR (CDCl3, 400 MHz) δ 9.27 (br s, 1H, NH), 7.51 (s,
1H, H6), 7.42−7.40 (m, 2H, DMTr), 7.33−7.23 (m, 7H, DMTr),
6.86−6.83 (m, 4H, DMTr), 6.28 (t, 1H, J = 6.6 Hz, H1′), 4.55 (m, 1H,
H3′), 4.05 (m, 1H, H4′), 3.79 (s, 6H, 2 × OCH3), 3.41 (dd, J = 10.4,
3.2 Hz, 1H, H5′), 3.33 (dd, J = 10.4, 3.2 Hz, 1H, H5′), 2.47 (m, 1H,
H2′), 2.25 (m, 1H, H2′); 13C NMR (CDCl3, 100 MHz) δ 159.5 (C4),
158.8 (DMTr), 149.0 (C2), 144.5, 135.6, 135.4, 130.22, 130.20, 128.1
(DMTr), 127.4, 127.2 (C6, DMTr), 115.6 (C5), 113.4, (DMTr), 87.3
(DMTr), 86.4 (C4′) 85.5 (C1′), 72.2 (C3′), 63.4 (C5′), 55.4
(OCH3), 41.3 (C2′); HR ESI MS m/z 594.1948 ([M + Na]+,
C30H29N5O7Na+ calcd 594.1959).
5′-(4,4′-Dimethoxytrityl)-5-(4-phenyl)-1,2,3-triazol-1-yl)-2′-deox-
yuridine (6). To a stirred solution of nucleoside 5 (170 mg, 0.29
mmol) and phenylacetylene (100 μL, 0.91 mmol) in a mixture of H2O,
t-BuOH, and pyridine (5 mL, 2:2:1, v/v/v) was added sodium
ascorbate (60 mg, 0.30 mmol) and CuSO4·5H2O (25 mg, 0.10 mmol),
and the reaction mixture was stirred at room temperature for 3 h. Ethyl
acetate (30 mL) was added, and the mixture was washed with H2O (20
mL) and a saturated aqueous solution of NaHCO3 (20 mL). The
combined aqueous phase was extracted with ethyl acetate (2 × 15
mL), and the combined organic phase was dried (Na2SO4) and
concentrated under reduced pressure. The residue was purified by
column chromatography (0−5% MeOH in CH2Cl2) to afford the
nucleoside 6 (130 mg, 65%) as a pale yellow solid: 1H NMR (DMSO-
d6, 400 MHz) δ 12.15 (s, 1H, NH), 8.53 (s, 1H, CH triazole), 8.27 (s,
1H, H6), 7.83 (d, J = 7.6 Hz, 2H, Ph), 7.46 (t, J = 7.6 Hz, 2H, Ph),
7.38−7.34 (m, 1H, Ph), 7.29−7.27 (m, 2H, DMTr), 7.23−7.19 (m,
2H, DMTr), 7.19−7.12 (m, 5H, DMTr), 6.82−6.79 (m, 4H, DMTr),
6.18 (t, J = 6.4 Hz, 1H, H1′), 5.37 (d, J = 4.4 Hz, 1H, 3′−OH), 4.27
(m, 1H, H3′), 3.95 (m, 1H, H4′), 3.67 (s, 6H, OCH3), 3.25 (dd, J =
10.4, 5.2 Hz, 1H, H5′), 3.11 (dd, J = 10.4, 2.6 Hz, 2H, H5′), 2.39−
2.30 (m, 2H, H2′); 13C NMR (DMSO-d6, 100 MHz) δ 158.6 (C4),
157.9, (DMTr), 149.1 (C2), 146.2 (C triazole), 144.5 (DMTr), 136.9
(C6), 135.3, 135.1, 130.1, 129.5, 129.4, 128.8, 127.9, 127.7, 127.4,
126.5, (Ph, DMTr), 125.2 (Ph), 123.0 (CH triazole), 113.0 (DMTr,
C5), 85.9, 85.7, 85.5 (C1′, C4′, DMTr), 70.2 (C3′), 63.5 (C5′), 54.8
(OCH3), 40.0 (C2′); HR ESI MS m/z 696.2398 ([M + Na]+,
C38H35N5O7Na+ calcd 696.2429).
3′-O-(P-(2-Cyanoethoxy)-N,N′-diisopropylaminophosphinyl)-5′-
O-(4,4′-dimethoxytrityl)-5-(4-phenyl)-1,2,3-triazol-1-yl)-2′-deoxyuri-
dine (7). The nucleoside 6 (120 mg, 0.17 mmol) was coevaporated
with anhydrous 1,2-dichloroethane (2 × 5 mL) and dissolved in
anhydrous CH2Cl2 (5 mL). N,N-Diisopropylammonium tetrazolide
(72 mg, 0.36 mmol) and 2-cyanoethyl N,N,N′,N′-tetraisopropylphos-
phoramidite (120 μL, 0.35 mmol) were added, and the mixture was
stirred at room temperature for 14 h. The reaction was quenched by
the addition of 99.9% EtOH (4 drops), and the mixture was
concentrated under reduced pressure. The residue was purified by
column chromatography (0−2% MeOH in CH2Cl2) to afford the
product 7 (105 mg) as a white foam containing some hydrolyzed
phosphitylation reagent. The compound was used without further
purification in the ON synthesis: Rf 0.5 (3% MeOH in CH2Cl2); 31P
NMR (CDCl3, 162 MHz) δ 149.1, 148.8; HR ESI MS m/z 874.3685
([M + H]+, C47H53N7O8PH+ calcd 874.3688).
1
d6) δ = 10.04 (br s, 1H, NH), 7.51−7.48 (m, 2H, Ar), 7.36−7.29 (m,
3
2H, Ar), 4.41 (d, JHH = 5.9 Hz, 2H, CH2); 13C NMR (101 MHz,
2
DMSO) δ = 156.5 (q, JCF = 36 Hz, CO), 140.2, 130.7, 130.2,
130.2, 126.4, 121.7 (Ar), 115.9 (q, 1JCF = 288 Hz, CF3), 42.0 (d, 4JCF
=
5 Hz, CH2); 19F NMR (376 MHz, DMSO-d6) δ = −74.3 (s, CF3); HR
ESI MS m/z = 281.9741 ([M + H+, 81Br], C9H8BrF3NO+ calcd
281.9736).
5′-O-(4,4′-Dimethoxytrityl)-5-(1-(3-((2,2,2-trifluoroacetamido)-
methyl)phenyl)-1,2,3-triazol-4-yl)-2′-deoxyuridine (2). To a stirred
solution of N-(3-bromobenzyl)-2,2,2-trifluoroacetamide (423 mg, 1.5
mmol) in a mixture of ethanol and water (7:3, v/v, 3.0 mL) were
added NaN3 (97 mg, 1.5 mmol), CuI (28 mg, 0.15 mmol), N,N′-
dimethylethylenediamine (20 mg, 0.22 mmol), and sodium ascorbate
(15 mg, 0.07 mmol). The mixture was stirred under microwave
irradiation (100 W) at 100 °C for 60 min. N,N′-Dimethylethylenedi-
amine (20 mg, 0.22 mmol), sodium ascorbate (15 mg, 0.07 mmol),
CuI (28 mg, 0.15 mmol), and nucleoside 1 (332 mg, 0.60 mmol) were
added, and the mixture was stirred under microwave irradiation at 100
°C for 30 min. The reaction mixture was extracted with ethyl acetate
(2 × 15 mL), and the combined organic phase was dried (Na2SO4)
and concentrated under reduced pressure. The residue was purified by
silica gel column chromatography (0−5% MeOH in CH2Cl2) and then
coevaporated with toluene (10 mL) to afford the product 2 as a white
1
foam (348 mg, 72%): Rf 0.5 (5% MeOH/CH2Cl2, v/v); H NMR
(DMSO-d6, 400 MHz) δ 11.84 (br, 1H, NH(U)), 10.10 (t, J = 5.9 Hz,
1H, NHCO), 8.83 (s, 1H, CH triazole), 8.42 (s, 1H, H6), 7.89 (s, 1H,
Ar), 7.85 (d, J = 8.0 Hz, 1H, Ar), 7.58 (t, J = 8.0 Hz, 1H, Ar), 7.42−
7.37 (m, 3H, DMTr, Ar), 7.29−7.21 (m, 6H, DMTr), 7.19−7.11 (m,
3H, DMTr), 6.84−6.81 (m, 4H, DMTr), 6.20 (t, J = 6.4 Hz, 1H, H1′),
5.38 (d, J = 4.6 Hz, 1H, 3′−OH), 4.53 (d, J = 5.9 Hz, 2H, CH2NH),
4.22 (m, 1H, H3′), 3.97 (m, 1H, H4′), 3.66 (s, 6H, 2 × OCH3), 3.25−
3.22 (m, 2H, H5′), 2.30−2.26 (m, 2H, H2′); 13C NMR (DMSO-d6,
2
100 MHz) δ 161.1, 158.0, 156.4 (q, JCF = 36 Hz, COCF3), 149.5,
144.8, 139.9, 139.5, 136.6 (C6), 136.3, 135.5, 135.4, 130.1, 129.7,
129.6, 127.7, 127.6, 126.5, 119.9 (CH triazole), 119.1, 119.0, 115.9 (q,
1JCF = 288 Hz, CF3), 113.1, 104.6, 85.7 (C4′), 85.3 (C1′), 70.4 (C3′),
54.9 (OCH3), 42.2 (CH2), 39.9 (C2′); 19F NMR (DMSO-d6, 376
MHz). δ −74.29 (CF3); HR ESI MS m/z 821.2516 ([M + Na]+,
C41H37F3N6O8Na+ calcd 821.2517).
3′-O-(P-(2-Cyanoethoxy)-(N,N-diisopropylamino)phosphinyl)-5′-
O-(4,4′-dimethoxytrityl)-5-(1-(3-((2,2,2-trifluoroacetamido)methyl)-
phenyl)-1,2,3-triazol-4-yl)-2′-deoxyuridine (3). Nucleoside 2 (180
mg, 0.25 mmol) was coevaporated with anhydrous 1,2-dichloroethane
(2 × 5 mL) and dissolved in anhydrous CH2Cl2 (5.0 mL). N,N-
diisopropylethylamine (220 μL, 1.25 mmol), and 2-cyanoethyl-N,N-
diisopropylamino chlorophosphite (180 μL, 0.75 mmol) were added
and the reaction mixture was stirred at room temperature for 2 h. The
reaction was quenched by the addition of 99.9% EtOH (2−3 drops),
and the mixture was concentrated under reduced pressure. The residue
was purified by column chromatography (0−2% MeOH in CH2Cl2) to
afford the product 3 (125 mg, 54%) as a white foam: Rf 0.4 (2%
MeOH in CH2Cl2); 31P NMR (CDCl3, 162 MHz) δ 149.1, 148.7; HR
ESI MS m/z 1021.3625 ([M + Na]+, C50H54F3N8O9PNa+ calcd
1021.3596).
5-Azido-5′-(4,4′-dimethoxytrityl)-2′-deoxyuridine (5). Nucleoside
4 (270 mg, 1.0 mmol) was coevaporated with anhydrous pyridine (2 ×
10 mL) and redissolved in the same solvent (10 mL). 4,4′-
Dimethoxytrityl chloride (410 mg, 1.20 mmol) was added, and the
reaction mixture was stirred at room temperature for 14 h. The
reaction was quenched by the addition of EtOH (99.9%, 3−4 drops),
and the mixture was concentrated under reduced pressure. The residue
was coevaporated with toluene (2 × 10 mL), dissolved in CH2Cl2 (30
mL), and washed with a saturated aqueous solution of NaHCO3 (2 ×
20 mL). The combined aqueous phase was extracted with CH2Cl2 (2
× 20 mL), and the combined organic phase was dried (Na2SO4) and
concentrated under reduced pressure. The residue was purified by
column chromatography (0−5% MeOH in CH2Cl2) to give the
product 5 (240 mg, 42%) as a yellow solid: Rf 0.4 (5% MeOH in
5′-(4,4′-Dimethoxytrityloxymethyl)-5-phenyl-2′-deoxyuridine
(10). To a stirred solution of 5-phenyl-2′-deoxyuridine 9 (268 mg, 0.88
mmol) in a mixture of anhydrous CH3CN and pyridine (17 mL, 1:1,
v/v) was added 4,4′-dimethoxytrityl chloride (462 mg, 1.36 mmol).
The mixture was stirred at room temperature for 4 h and then
quenched by the addition of MeOH (4 mL). The mixture was
concentrated under reduced pressure, and the residue was dissolved in
CH2Cl2 (100 mL). The organic phase was washed with water (20 mL)
and a saturated aqueous solution of NaHCO3 (20 mL). The organic
phase was dried (MgSO4) and concentrated under reduced pressure.
The residue was purified by flash chromatography (10−100% ethyl
acetate in cyclohexane) to afford the product 10 (254 mg, 47%) as a
1
white amorphous solid: Rf 0.30 (5% MeOH in CH2Cl2); H NMR
(400 MHz, DMSO-d6) δ 11.60 (s, 1H, NH), 7.66 (s, 1H, H6), 7.30−
7.15 (m, 14H, Ph, DMTr), 6.77 (m, 4H, DMTr), 6.23 (t, J = 6.8 Hz,
1H, H1′), 5.34 (d, J = 4.4 Hz, 1H, 3′−OH), 4.29 (m, 1H, H3′), 3.93
2861
dx.doi.org/10.1021/jo4025896 | J. Org. Chem. 2014, 79, 2854−2863